跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
BIMZELX bimekizumab 160 mg/1 mL solution for injection safety syringe
Approved
STANDARD
BIMZELX bimekizumab 160 mg/1 mL solution for injection safety syringe
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
17e6f3d9d85073ce
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
17e6f3d9d85073ce
Product Name
BIMZELX bimekizumab 160 mg/1 mL solution for injection safety syringe
Artg Id
353269
Artg Name
Bimzelx bimekizumab 160 mg/1 mL solution for injection safety syringe
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2022-03-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/cce850123b52639f37e235b744067c34.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/ed0ab301ebc6560a42d8e1031fa51731.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
17e6f3d9d85073ce
Type
Standard
Back to TGA Approvals
BIMZELX bimekizumab 160 mg/1 mL solution for injection safety syringe - TGA Drug Approval Details
